Literature DB >> 15270863

Osteoprotegerin (OPG) acts as an endogenous decoy receptor in tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis of fibroblast-like synovial cells.

T Miyashita1, A Kawakami, T Nakashima, S Yamasaki, M Tamai, F Tanaka, M Kamachi, H Ida, K Migita, T Origuchi, K Nakao, K Eguchi.   

Abstract

We examined the role of osteoprotegerin (OPG) on tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in rheumatoid fibroblast-like synovial cells (FLS). OPG protein concentrations in synovial fluid from patients with rheumatoid arthritis (RA) correlated with those of interleukin (IL)-1beta or IL-6. A similar correlation was present between IL-1beta and IL-6 concentrations. Rheumatoid FLS in vitro expressed both death domain-containing receptors [death receptor 4 (DR4) and DR5] and decoy receptors [decoy receptor 1 (DcR1) and DcR2]. DR4 expression on FLS was weak compared with the expression of DR5, DcR1 and DcR2. Recombinant TRAIL (rTRAIL) rapidly induced apoptosis of FLS. DR5 as well as DR4 were functional with regard to TRAIL-mediated apoptosis induction in FLS; however, DR5 appeared be more efficient than DR4. In addition to soluble DR5 (sDR5) and sDR4, OPG administration significantly inhibited TRAIL-induced apoptogenic activity. OPG was identified in the culture supernatants of FLS, and its concentration increased significantly by the addition of IL-1beta in a time-dependent manner. Neither IL-6 nor tumour necrosis factor (TNF)-alpha increased the production of OPG from FLS. TRAIL-induced apoptogenic activity towards FLS was reduced when rTRAIL was added without exchanging the culture media, and this was particularly noticeable in the IL-1beta-stimulated FLS culture; however, the sensitivity of FLS to TRAIL-induced apoptosis itself was not changed by IL-1beta. Interestingly, neutralization of endogenous OPG by adding anti-OPG monoclonal antibody (MoAb) to FLS culture restored TRAIL-mediated apoptosis. Our data demonstrate that OPG is an endogenous decoy receptor for TRAIL-induced apoptosis of FLS. In addition, IL-1beta seems to promote the growth of rheumatoid synovial tissues through stimulation of OPG production, which interferes with TRAIL death signals in a competitive manner.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15270863      PMCID: PMC1809120          DOI: 10.1111/j.1365-2249.2004.02534.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

Authors:  W S Simonet; D L Lacey; C R Dunstan; M Kelley; M S Chang; R Lüthy; H Q Nguyen; S Wooden; L Bennett; T Boone; G Shimamoto; M DeRose; R Elliott; A Colombero; H L Tan; G Trail; J Sullivan; E Davy; N Bucay; L Renshaw-Gegg; T M Hughes; D Hill; W Pattison; P Campbell; S Sander; G Van; J Tarpley; P Derby; R Lee; W J Boyle
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

2.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

3.  Elevated levels of osteoprotegerin (OPG) and hepatocyte growth factor (HGF) in rheumatoid arthritis.

Authors:  A J Feuerherm; M Borset; C Seidel; A Sundan; L Leistad; M Ostensen; A Faxvaag
Journal:  Scand J Rheumatol       Date:  2001       Impact factor: 3.641

4.  Inhibition of Fas antigen-mediated apoptosis of rheumatoid synovial cells in vitro by transforming growth factor beta 1.

Authors:  A Kawakami; K Eguchi; N Matsuoka; M Tsuboi; Y Kawabe; T Aoyagi; S Nagataki
Journal:  Arthritis Rheum       Date:  1996-08

5.  The receptor for the cytotoxic ligand TRAIL.

Authors:  G Pan; K O'Rourke; A M Chinnaiyan; R Gentz; R Ebner; J Ni; V M Dixit
Journal:  Science       Date:  1997-04-04       Impact factor: 47.728

6.  TRAIL-R2 (DR5) mediates apoptosis of synovial fibroblasts in rheumatoid arthritis.

Authors:  Kimihisa Ichikawa; Weimin Liu; Martin Fleck; Huangge Zhang; Limin Zhao; Toshiaki Ohtsuka; Zheng Wang; Di Liu; John D Mountz; Masahiko Ohtsuki; William J Koopman; Robert Kimberly; Tong Zhou
Journal:  J Immunol       Date:  2003-07-15       Impact factor: 5.422

7.  Akt is an endogenous inhibitor toward tumor necrosis factor-related apoptosis inducing ligand-mediated apoptosis in rheumatoid synovial cells.

Authors:  Taiichiro Miyashita; Atsushi Kawakami; Mami Tamai; Yasumori Izumi; Huang Mingguo; Fumiko Tanaka; Seigou Abiru; Koto Nakashima; Nozomi Iwanaga; Koichiro Aratake; Makoto Kamachi; Kazuhiko Arima; Hiroaki Ida; Kiyoshi Migita; Tomoki Origuchi; Shuzo Tagashira; Fumio Nishikaku; Katsumi Eguchi
Journal:  Biochem Biophys Res Commun       Date:  2003-12-12       Impact factor: 3.575

8.  Fas antigen expression on synovial cells was down-regulated by interleukin 1 beta.

Authors:  M Tsuboi; K Eguchi; A Kawakami; N Matsuoka; Y Kawabe; T Aoyagi; K Maeda; S Nagataki
Journal:  Biochem Biophys Res Commun       Date:  1996-01-05       Impact factor: 3.575

9.  TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption.

Authors:  B S Kwon; S Wang; N Udagawa; V Haridas; Z H Lee; K K Kim; K O Oh; J Greene; Y Li; J Su; R Gentz; B B Aggarwal; J Ni
Journal:  FASEB J       Date:  1998-07       Impact factor: 5.191

10.  Cytokines and acute phase proteins in rheumatoid arthritis.

Authors:  G W Duff
Journal:  Scand J Rheumatol Suppl       Date:  1994
View more
  20 in total

1.  Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes.

Authors:  K Varani; F Vincenzi; A Tosi; M Targa; F F Masieri; A Ongaro; M De Mattei; L Massari; P A Borea
Journal:  Br J Pharmacol       Date:  2010-03-19       Impact factor: 8.739

Review 2.  TNF-related apoptosis-inducing ligand (TRAIL) in rheumatoid arthritis: what's new?

Authors:  Anna Neve; Addolorata Corrado; Francesco Paolo Cantatore
Journal:  Clin Exp Med       Date:  2012-12-30       Impact factor: 3.984

3.  Trichostatin A sensitises rheumatoid arthritis synovial fibroblasts for TRAIL-induced apoptosis.

Authors:  A Jüngel; V Baresova; C Ospelt; B R Simmen; B A Michel; R E Gay; S Gay; C A Seemayer; M Neidhart
Journal:  Ann Rheum Dis       Date:  2005-11-10       Impact factor: 19.103

4.  Effect of triptolide on expression of receptor activator of nuclear factor-kappaB ligand in rat adjuvant induced arthritis.

Authors:  Yonghong Hu; Bo Luo; Mingmin Zhang; Shenghao Tu; Keqing Zeng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

5.  Different expression levels of TNF receptors on the rheumatoid synovial macrophages derived from surgery and a synovectomy as detected by a new flow cytometric analysis.

Authors:  Hiroaki Ida; Toshiyuki Aramaki; Hideki Nakamura; Keita Fujikawa; Kazuhiko Arima; Mami Tamai; Makoto Kamachi; Katsuya Satoh; Tomoki Origuchi; Atsushi Kawakami; Itaru Furuichi; Yojiro Kawabe; Katsumi Eguchi
Journal:  Cytotechnology       Date:  2009-09-26       Impact factor: 2.058

Review 6.  TNF superfamily: a growing saga of kidney injury modulators.

Authors:  Maria D Sanchez-Niño; Alberto Benito-Martin; Sara Gonçalves; Ana B Sanz; Alvaro C Ucero; Maria C Izquierdo; Adrian M Ramos; Sergio Berzal; Rafael Selgas; Marta Ruiz-Ortega; Jesus Egido; Alberto Ortiz
Journal:  Mediators Inflamm       Date:  2010-10-04       Impact factor: 4.711

7.  Targeting a novel N-terminal epitope of death receptor 5 triggers tumor cell death.

Authors:  Peng Zhang; Yong Zheng; Juan Shi; Yaxi Zhang; Shilian Liu; Yanxin Liu; Dexian Zheng
Journal:  J Biol Chem       Date:  2010-01-27       Impact factor: 5.157

8.  Inhibition of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertension.

Authors:  Abdul G Hameed; Nadine D Arnold; Janet Chamberlain; Josephine A Pickworth; Claudia Paiva; Sarah Dawson; Simon Cross; Lu Long; Lan Zhao; Nicholas W Morrell; David C Crossman; Christopher M H Newman; David G Kiely; Sheila E Francis; Allan Lawrie
Journal:  J Exp Med       Date:  2012-10-15       Impact factor: 14.307

9.  Cells of the synovium in rheumatoid arthritis. Synovial fibroblasts.

Authors:  Ulf Müller-Ladner; Caroline Ospelt; Steffen Gay; Oliver Distler; Thomas Pap
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

10.  Elevated expression of caspase-3 inhibitors, survivin and xIAP correlates with low levels of apoptosis in active rheumatoid synovium.

Authors:  Anak A S S K Dharmapatni; Malcolm D Smith; David M Findlay; Christopher A Holding; Andreas Evdokiou; Michael J Ahern; Helen Weedon; Paul Chen; Gavin Screaton; Xiao N Xu; David R Haynes
Journal:  Arthritis Res Ther       Date:  2009-01-27       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.